MEDROL ACETATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Medrol Acetate, and when can generic versions of Medrol Acetate launch?
Medrol Acetate is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in MEDROL ACETATE is methylprednisolone acetate. There are forty drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Medrol Acetate
A generic version of MEDROL ACETATE was approved as methylprednisolone acetate by HONG KONG on February 23rd, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MEDROL ACETATE?
- What are the global sales for MEDROL ACETATE?
- What is Average Wholesale Price for MEDROL ACETATE?
Summary for MEDROL ACETATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 55 |
| Clinical Trials: | 2 |
| Patent Applications: | 4,150 |
| DailyMed Link: | MEDROL ACETATE at DailyMed |
Recent Clinical Trials for MEDROL ACETATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Fayoum University Hospital | Phase 4 |
| Mercy Health Ohio | Phase 4 |
US Patents and Regulatory Information for MEDROL ACETATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | MEDROL ACETATE | methylprednisolone acetate | OINTMENT;TOPICAL | 012421-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmacia And Upjohn | MEDROL ACETATE | methylprednisolone acetate | OINTMENT;TOPICAL | 012421-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
